2023
CMS, in its 2023 RADV rule, estimated $17 billion in annual Medicare Advantage overpayments from unsupported diagnosis codes.
“I think CMS, when they came out with the 2023 ruling, they had estimated $17 billion in annual MA overpayments from unsupported diagnosis codes.”
Dave DeHommel · Navigating Risk Adjustment Data Validation (RADV) Audits with Confidence, and the Costs of Unsupported Diagnoses, 0:02:17
2024
Halamka says a draft CMS non-discrimination rule states AI should augment human decision-making and the doctor stays responsible.
“He said AI should be an augmentation to human decision-making.”
John Halamka · Data, AI, and Patient Outcomes: Inside the Mayo Clinic Platform, 0:39:36
2025
CMS appealed the Texas court's ruling on its RADV extrapolation methodology in November 2025.
“And as we know, CMS did appeal that ruling back in November of 2025.”
Dave DeHommel · Navigating Risk Adjustment Data Validation (RADV) Audits with Confidence, and the Costs of Unsupported Diagnoses, 0:03:00
2026
CMS plans to audit four additional payment years in calendar year 2026 and the remaining two in 2027, according to Dave DeHommel.
“But catching up with four additional payment year audits in calendar year 2026 and the remaining two in 2027, health plans have to focus and really execute in this area moving forward.”
Dave DeHommel · Navigating Risk Adjustment Data Validation (RADV) Audits with Confidence, and the Costs of Unsupported Diagnoses, 0:05:26
2026
Dave DeHommel says CMS's final notice this year introduced claims-linking criteria tying retrospective chart review documentation to an encounter.
“the advance notice just kind of reinforced tying the retrospective chart retrieval encoding documentation to the encounter through their claims linking criteria that was new and came out in the final notice this year.”
Dave DeHommel · Navigating Risk Adjustment Data Validation (RADV) Audits with Confidence, and the Costs of Unsupported Diagnoses, 0:15:31
2027
Starting with 2027 dates of service, retrospective chart review results that affect a plan's risk score must be linked to an encounter.
“starting on 2027 dates of service, the results of retrospective chart retrieval and coding projects, if it is going to impact the health plan's risk score calculation, it must be linked now to an encounter.”
Dave DeHommel · Navigating Risk Adjustment Data Validation (RADV) Audits with Confidence, and the Costs of Unsupported Diagnoses, 0:15:31
2027
Parts of a federal interoperability rule are set to take effect in 2027, requiring new data interfaces.
“other parts of the interoperability rule coming into play in 2027.”
Elizabeth Casalo · Karen Ignagni on Affordability, Medicaid and the Future of Health Insurance, 0:07:58
Undated
Michael Abramoff says the Federal Register contains about 30 pages in which CMS discussed its concerns and guardrails about paying for autonomous AI.
“There's literally 30 pages in the Federal Register from CMS discussing their worries and concerns, what they called guardrails”
Michael Abramoff · No Doctor Needed? Dr. Michael Abramoff on the Potential of Autonomous AI, 0:29:14
Undated
Michael Abramoff says the relevant part of CMS can only reimburse what a physician charges because of how the Social Security Act was written.
“the part of CMS that we're talking about here is only allowed to reimburse what a physician charge. That's the way the Social Security Act was written.”
Michael Abramoff · No Doctor Needed? Dr. Michael Abramoff on the Potential of Autonomous AI, 0:33:18
Undated
Mark Cuban says studies from Harvard and Vanderbilt compared Medicare's drug payments with Cost Plus Drugs prices, finding large potential savings.
“there've been studies done, Harvard and Vanderbilt, et cetera, where they've compared the price that CMS pays for various medications versus if they bought from us”
Mark Cuban · Mark Cuban on AI, Trust in Health Care, and Skip Bayless, 0:19:16
Undated
Humana challenged CMS's RADV rule, and a federal district court in Texas vacated it.
“that RADV ruling was challenged by Humana. And a federal district court in Texas essentially vacated that ruling.”
Dave DeHommel · Navigating Risk Adjustment Data Validation (RADV) Audits with Confidence, and the Costs of Unsupported Diagnoses, 0:02:17
Undated
The CMS extrapolation methodology that excluded the fee-for-service adjuster was vacated and is not currently applicable, according to Dave DeHommel.
“the extrapolation methodology that CMS defined, which excluded that fee-for-service adjuster is no longer applicable.”
Dave DeHommel · Navigating Risk Adjustment Data Validation (RADV) Audits with Confidence, and the Costs of Unsupported Diagnoses, 0:03:00